Wells Fargo’s Zimmer Biomet ZBH Stock Holding History

Wells Fargo’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-36,050	Closed	-$587K	–	7473
2020 Q4	$587K	Buy	36,050 +7,622	+27%	+$1.08M	﹤0.01%	4410
2020 Q3	$144K	Hold	28,428	–	–	﹤0.01%	5114
2020 Q2	$468K	Sell	28,428 -20,909	-42%	-$2.41M	﹤0.01%	4377
2020 Q1	$2.12M	Hold	49,337	–	–	﹤0.01%	2953
2019 Q4	$326K	Sell	49,337 -14,111	-22%	-$1.95M	﹤0.01%	4683
2019 Q3	$116K	Hold	63,448	–	–	﹤0.01%	5251
2019 Q2	$659K	Sell	63,448 -39,552	-38%	-$4.63M	﹤0.01%	4187
2019 Q1	$151K	Hold	103,000	–	–	﹤0.01%	4959
2018 Q4	$1.32M	Buy	103,000 +54,899	+114%	+$6.17M	﹤0.01%	3629
2018 Q3	$147K	Buy	+48,101	New	+$5.72M	﹤0.01%	5176

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wells Fargo's ZBH Position: Q2 2026 in Review

Wells Fargo reduced its Zimmer Biomet (ZBH) stake by 0.5% in Q2 2026, selling an estimated $78.7K and leaving 178,591 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1850.

Wells Fargo first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $372M in Q2 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Wells Fargo held 178,591 shares of Zimmer Biomet worth $15.4M as of Q2 2026.
Wells Fargo sold 897 Zimmer Biomet shares in Q2 2026, an estimated $78.7K.
Zimmer Biomet made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1850 holding.
Wells Fargo first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Zimmer Biomet position peaked at $372M in Q2 2021.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.